{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:47:45Z","timestamp":1779241665634,"version":"3.51.4"},"reference-count":28,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Francaise contre les Myopathies","doi-asserted-by":"publisher","award":["23760"],"award-info":[{"award-number":["23760"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>The identification of metabolomic biomarkers relies on the analysis of large cohorts of patients compared to healthy controls followed by the validation of markers in an independent sample set. Indeed, circulating biomarkers should be causally linked to pathology to ensure that changes in the marker precede changes in the disease. However, this approach becomes unfeasible in rare diseases due to the paucity of samples, necessitating the development of new methods for biomarker identification. The present study describes a novel approach that combines samples from both mouse models and human patients to identify biomarkers of OPMD. We initially identified a pathology-specific metabolic fingerprint in murine dystrophic muscle. This metabolic fingerprint was then translated into (paired) murine serum samples and then to human plasma samples. This study identified a panel of nine candidate biomarkers that could predict muscle pathology with a sensitivity of 74.3% and specificity of 100% in a random forest model. These findings demonstrate that the proposed approach can identify biomarkers with good predictive performance and a higher degree of confidence in their relevance to pathology than markers identified in a small cohort of human samples alone. Therefore, this approach has a high potential utility for identifying circulating biomarkers in rare diseases.<\/jats:p>","DOI":"10.3390\/metabo13060769","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T02:26:56Z","timestamp":1687228016000},"page":"769","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD)"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-7420","authenticated-orcid":false,"given":"Pradeep","family":"Harish","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3GE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Malerba","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Royal Holloway University of London, Egham TW20 0EX, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-0649","authenticated-orcid":false,"given":"Rosemarie H. M. J. M.","family":"Kroon","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Donder Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, 6525AJ Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milad","family":"Shademan","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Leiden University Medical Centre, 2333ZC Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baziel","family":"van Engelan","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Donder Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, 6525AJ Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-1952","authenticated-orcid":false,"given":"Vered","family":"Raz","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Leiden University Medical Centre, 2333ZC Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Popplewell","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Royal Holloway University of London, Egham TW20 0EX, Surrey, UK"},{"name":"National Horizons Centre, Teesside University, Darlington DL1 1HG, County Durham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart G.","family":"Snowden","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Royal Holloway University of London, Egham TW20 0EX, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"ref_1","unstructured":"World Health Organisation (2001). International Programme on Chemical Safety Biomarkers in Risk Assessment: Validity and Validation, World Health Organisation."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are Biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1200\/JCO.2015.63.3651","article-title":"Biomarker: Predictive or Prognostic?","volume":"33","author":"Ballman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103577","DOI":"10.1016\/j.ebiom.2021.103577","article-title":"Personalising cancer medicine with prognostic markers","volume":"72","author":"Kerr","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8208609","DOI":"10.1155\/2017\/8208609","article-title":"Biomarkers of Cardiovascular Disease","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis. Markers"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tolstikov, V., Moser, A.J., Sarangarajan, R., Narain, N.R., and Kiebish, M.A. (2020). Current status of metabolomic biomarker discovery: Impact of study design and demographic characteristics. Metabolites, 10.","DOI":"10.3390\/metabo10060224"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pinu, F.R., Beale, D.J., Pate, A.M., Kouremenos, K., Swarup, S., Schirra, H.J., and Wishart, D.W. (2019). Systems biology and mutli-omics integration: Viewpoints from the metabolomics research community. Metabolites, 9.","DOI":"10.3390\/metabo9040076"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hardikar, S., Albrechtsen, R.D., Achaintre, D., Lin, T., Pauleck, S., Playdon, M., Holowatyj, A.N., Gigic, B., Schrotz-King, P., and Boehm, J. (2020). Impact of pre-blood collection factors on plasma metabolomic profiles. Metabolites, 10.","DOI":"10.3390\/metabo10050213"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3322\/caac.21670","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Harshfield, E.L., Fauman, E.B., Stacey, D., Paul, D.S., Ziemek, D., Ong, R.M.Y., Danesh, J., Butterworth, A.S., Rasheed, A., and Sattar, T. (2021). Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci. BMC Med., 19.","DOI":"10.1186\/s12916-021-02087-1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11306-020-01703-0","article-title":"Combining lipidomics and machine learning to measure clinical lipids in dried blood spots","volume":"16","author":"Snowden","year":"2020","journal-title":"Metabolomics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbadis.2006.10.003","article-title":"Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies","volume":"1772","author":"Rouleau","year":"2007","journal-title":"Biochim. Biophys. Acta\u2013Mol. Basis Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2015.014","article-title":"Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of Oculopharyngeal Muscular Dystrophy","volume":"26","author":"Harish","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000226594","article-title":"Populations screening for genetic disorders in the 21st century: Evidence, economics and ethics","volume":"13","author":"Grosse","year":"2010","journal-title":"Public Health Genom."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jcsm.12438","article-title":"Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)","volume":"10","author":"Harish","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/hmg\/ddq098","article-title":"Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres","volume":"19","author":"Trollet","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/hmg\/ddz007","article-title":"Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy","volume":"28","author":"Malerba","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1038\/ncomms14848","article-title":"PABPN1 gene therapy for oculopharyngeal muscular dystrophy","volume":"8","author":"Malerba","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Raz, V., Kroon, R.H.M.J.M., Mei, H., Riaz, M., Buermans, H., Lassche, S., Horlings, C., De Swart, B., Kalf, J., and Harish, P. (2020). Age-associated salivary microRNA biomarkers for oculopharyngeal muscular dystrophy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176059"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41431-018-0302-4","article-title":"Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools","volume":"27","author":"Garnier","year":"2019","journal-title":"Eur. J. Hum. Gen."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ebshiana, A.A., Snowden, S.G., Thambisetty, M., Parsons, R., Hye, A., and Legido-Quigley, C. (2015). Metabolomics method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122883"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Fernandes, H.J.R., Kent, J.P., Bruntraeger, M., Bassett, A.R., Koulman, A., Metzakopian, E., and Snowden, S.G. (2023). Mitochondrial and endoplasmic reticulum stress trigger triglyceride accumulation in models of Parkinson\u2019s disease independent of mutations in MAPT. Metabolites, 13.","DOI":"10.3390\/metabo13010112"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/ac202450g","article-title":"CAMERA: An integrated strategy for compound spectra extraction and annotation of liquid chromatography\/mass spectrometry datasets","volume":"84","author":"Kuhl","year":"2012","journal-title":"Anal. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-132165","article-title":"Metabolomic signatures in peripheral blood associated with Alzheimer\u2019s disease Amyloid-\u03b2-induced neuroinflammation","volume":"42","author":"Eosu","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ostergaard, S.D., Mukherjee, S., Sharp, S.J., Proitsi, P., Lotta, L.A., Day, F., Perry, J.R.B., Boehme, K.L., Walter, S., and Kauwe, J.S. (2015). Association between potentially modifiable risk factors and Alzheimer\u2019s Disease: A mendelian randomization study. PLoS Med., 12.","DOI":"10.1371\/journal.pmed.1001841"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading mendelian randomisation studies: A guide, glossary and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/6\/769\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:56:38Z","timestamp":1760126198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/6\/769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["metabo13060769"],"URL":"https:\/\/doi.org\/10.3390\/metabo13060769","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]}}}